J. Xu

发表

Structural insights into the design of small molecule inhibitors that selectively antagonize Mcl-1.

Chun Meng Song, J. Tong, C. Chai, 2010, Journal of medicinal chemistry.

Synthesis of a rhodanine-based compound library targeting Bcl-XL and Mcl-1

Chun Meng Song, J. Tong, C. Chai, 2011 .

Synthesis of Novel Sulfonamide-Based Calpain Inhibitors and Their Potential as Anti-Tumor Agents

J. Xu, 2019 .

Synthesis of Novel Sulfonamide-Based Calpain Inhibitors and Their Potential as Anti-Tumor Agents

J. Xu, 2016 .

Synthesis of Novel Sulfonamide-Based Calpain Inhibitors and Their Potential as Anti-Tumor Agents

J. Xu, 2007 .

Design, synthesis and biological evaluation of FLT3 covalent inhibitors with a resorcylic acid core.

Jeffrey Hill, C. Chai, J. Xu, 2014, Bioorganic & medicinal chemistry.

Synthesis of novel β-amino ketones containing a p-aminobenzoic acid moiety and evaluation of their antidiabetic activities

J. Xu, Xiao-li Song, L. Jiang, 2013, Science China Chemistry.

Synthesis and antiproliferative activity of sulfonamide-based peptidomimetic calpain inhibitors.

J. Xu, I. Donkor, Jiuyu Liu, 2020, Bioorganic & medicinal chemistry.

First Synthesis of (±)-C-3-Prenylated Flavanones

Haishan Wang, J. Xu, Mui Mui Sim, 2003 .

Structure-activity relationship studies of phenanthridine-based Bcl-XL inhibitors.

C. Chai, T. Sivaraman, P. Bernardo, 2008, Journal of medicinal chemistry.

Synthesis and antidiabetic performance of β-amino ketone containing nabumetone moiety.

J. Xu, Xiao-li Song, Hang Wang, 2012, Bioorganic & medicinal chemistry.

[Synthesis and alpha-glucosidase inhibitory activity of N-(1,5-diaryl-3-pentone-1-yl)-4-aminobenzoic acid].

J. Xu, Xiao-li Song, Da-cheng Yang, 2009, Yao xue xue bao = Acta pharmaceutica Sinica.

l-Threonine-catalysed asymmetric α-hydroxymethylation of cyclohexanone: application to the synthesis of pharmaceutical compounds and natural products

C. Chai, J. Xu, Anqi Chen, 2010 .

Concise Formal Synthesis of (S)-Gregatin B

J. Xu, K. Nishiwaki, K. Matsuo, 2005 .

Synthesis and biological activity of 2-alkylbenzimidazoles bearing a N-phenylpyrrole moiety as novel angiotensin II AT1 receptor antagonists.

W. Hua, Yi Zeng, Qiujuan Wang, 2007, Bioorganic & medicinal chemistry letters.

Exploring aigialomycin d and its analogues as protein kinase inhibitors for cancer targets.

C. Chai, J. Xu, K. Nacro, 2011, ACS medicinal chemistry letters.

Isolation of streptonigrin and its novel derivative from Micromonospora as inducing agents of p53-dependent cell apoptosis.

M. Sim, Haishan Wang, J. Xu, 2002, Journal of natural products.

Chemo‐Enzymatic Synthesis of Pyrazines and Pyrroles

A. Green, N. Turner, J. Xu, 2018, Angewandte Chemie.

Synthesis of phosphine oxide based amphiphilic molecules via ring-opening Wittig olefination of a macrocyclic phosphoranylidene and their property study as non-ionic surfactants

J. Xu, Kok-Ping Chan, Anqi Chen, 2018, RSC advances.

sphine oxide based amphiphilic molecules via ring-opening Wittig ole fi nation of a macrocyclic phosphoranylidene and their property study as non-ionic surfactants †

J. Xu, Kok-Ping Chan, Anqi Chen, 2018 .

[Synthesis and investigation on antidiabetic activity of 4-(1-aryl-3-oxo-5-phenylpentylamino) benzenesulfonamide].

Wei-yu Zhang, Xin Chen, J. Xu, 2010, Yao xue xue bao = Acta pharmaceutica Sinica.

Rational Design of Resorcylic Acid Lactone Analogues as Covalent MNK1/2 Kinase Inhibitors by Tuning the Reactivity of an Enamide Michael Acceptor

Jeffrey Hill, C. Chai, J. Xu, 2013, ChemMedChem.

Design and synthesis of 2-alkylbenzimidazole derivatives as novel non-peptide angiotensin II AT1 receptor antagonists

W. Hua, Qiujuan Wang, J. Xu, 2007 .

Exploring aigialomycin d and its analogues as protein kinase inhibitors for cancer targets.

C. Chai, J. Xu, K. Nacro, 2011, ACS medicinal chemistry letters.